These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 22020560

  • 1. MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer.
    Song Y, Xu Y, Wang Z, Chen Y, Yue Z, Gao P, Xing C, Xu H.
    Int J Cancer; 2012 Sep 01; 131(5):1042-51. PubMed ID: 22020560
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation.
    Song YX, Yue ZY, Wang ZN, Xu YY, Luo Y, Xu HM, Zhang X, Jiang L, Xing CZ, Zhang Y.
    Mol Cancer; 2011 Jan 04; 10():1. PubMed ID: 21205300
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome proliferator-activated receptor γ-mediated induction of microRNA-145 opposes tumor phenotype in colorectal cancer.
    Panza A, Votino C, Gentile A, Valvano MR, Colangelo T, Pancione M, Micale L, Merla G, Andriulli A, Sabatino L, Vinciguerra M, Prattichizzo C, Mazzoccoli G, Colantuoni V, Piepoli A.
    Biochim Biophys Acta; 2014 Jun 04; 1843(6):1225-36. PubMed ID: 24631504
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
    Xiong B, Cheng Y, Ma L, Zhang C.
    Int J Oncol; 2013 Jan 04; 42(1):219-28. PubMed ID: 23174819
    [Abstract] [Full Text] [Related]

  • 6. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
    Zhang C, Liu J, Tan C, Yue X, Zhao Y, Peng J, Wang X, Laddha SV, Chan CS, Zheng S, Hu W, Feng Z.
    Oncotarget; 2016 Feb 23; 7(8):8783-96. PubMed ID: 26840028
    [Abstract] [Full Text] [Related]

  • 7. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
    Gopalan V, Pillai S, Ebrahimi F, Salajegheh A, Lam TC, Le TK, Langsford N, Ho YH, Smith RA, Lam AK.
    Mol Carcinog; 2014 Feb 23; 53 Suppl 1():E36-44. PubMed ID: 24009195
    [Abstract] [Full Text] [Related]

  • 8. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
    Schepeler T, Holm A, Halvey P, Nordentoft I, Lamy P, Riising EM, Christensen LL, Thorsen K, Liebler DC, Helin K, Ørntoft TF, Andersen CL.
    Oncogene; 2012 May 31; 31(22):2750-60. PubMed ID: 21963845
    [Abstract] [Full Text] [Related]

  • 9. C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer.
    Sun D, Wang C, Long S, Ma Y, Guo Y, Huang Z, Chen X, Zhang C, Chen J, Zhang J.
    Br J Cancer; 2015 Apr 28; 112(9):1491-500. PubMed ID: 25867276
    [Abstract] [Full Text] [Related]

  • 10. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
    Tang JT, Wang JL, Du W, Hong J, Zhao SL, Wang YC, Xiong H, Chen HM, Fang JY.
    Carcinogenesis; 2011 Aug 28; 32(8):1207-15. PubMed ID: 21665895
    [Abstract] [Full Text] [Related]

  • 11. Characterization of gastrin-cholecystokinin 2 receptor interaction in relation to c-fos induction.
    Hollestelle MJ, Timmerman P, Meloen RH, Höppener JW.
    Endocr Relat Cancer; 2008 Mar 28; 15(1):301-9. PubMed ID: 18310296
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-497 inhibits tumor growth and increases chemosensitivity to 5-fluorouracil treatment by targeting KSR1.
    Wang L, Jiang CF, Li DM, Ge X, Shi ZM, Li CY, Liu X, Yin Y, Zhen L, Liu LZ, Jiang BH.
    Oncotarget; 2016 Jan 19; 7(3):2660-71. PubMed ID: 26673620
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-29b is a Novel Prognostic Marker in Colorectal Cancer.
    Inoue A, Yamamoto H, Uemura M, Nishimura J, Hata T, Takemasa I, Ikenaga M, Ikeda M, Murata K, Mizushima T, Doki Y, Mori M.
    Ann Surg Oncol; 2015 Dec 19; 22 Suppl 3():S1410-8. PubMed ID: 25472644
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-33b inhibits tumor cell growth and is associated with prognosis in colorectal cancer patients.
    Liao W, Gu C, Huang A, Yao J, Sun R.
    Clin Transl Oncol; 2016 May 19; 18(5):449-56. PubMed ID: 26329295
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory effect of upregulated DR-nm23 expression on invasion and metastasis in colorectal cancer.
    Qu L, Liang L, Su J, Yang Z.
    Eur J Cancer Prev; 2013 Nov 19; 22(6):512-22. PubMed ID: 23765094
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. miR-21 and its target gene CCL20 are both highly overexpressed in the microenvironment of colorectal tumors: significance of their regulation.
    Vicinus B, Rubie C, Stegmaier N, Frick VO, Kölsch K, Kauffels A, Ghadjar P, Wagner M, Glanemann M.
    Oncol Rep; 2013 Sep 19; 30(3):1285-92. PubMed ID: 23817679
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Enhanced expression of cholecystokinin-2 receptor promotes the progression of colon cancer through activation of focal adhesion kinase.
    Yu HG, Tong SL, Ding YM, Ding J, Fang XM, Zhang XF, Liu ZJ, Zhou YH, Liu QS, Luo HS, Yu JP.
    Int J Cancer; 2006 Dec 15; 119(12):2724-32. PubMed ID: 16998832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.